Reference no: EM133899306

Question

Genetic testing is transforming biomedical research, particularly in the context of drug trials. Although the healthcare industry has made substantial progress in recent years, there is still considerable room for improvement in genetic testing. Genetic testing enables researchers to identify specific genetic markers that predict an individual's response to certain medications. This leads to more effective and personalized treatment plans. As mentioned in this week's assignment, there is an understandable concern for patient safety and privacy. Genetic testing and artificial intelligence models offer promising alternatives to traditional medicine; however, their successful application requires overcoming several challenges (Del Arco de la Paz et al., 2024). In drug trials, genetic testing can help select participants who are more likely to benefit from the treatment, thereby increasing the chances of trial success and reducing adverse effects. Participants must be fully informed about how their genetic data will be used in the trial, including understanding the implications of sharing their genetic information and the potential risks associated with it. As McBride & Tietze (2023) stated, "If patients do not trust that their EHR data are well protected and used to their advantage, the relationship with clinicians will suffer." (p. 374). The Health Insurance Portability.